These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 10841663)

  • 41. Effects of calcium supplements on the risk of renal stone formation in a population with low oxalate intake.
    Stitchantrakul W; Sopassathit W; Prapaipanich S; Domrongkitchaiporn S
    Southeast Asian J Trop Med Public Health; 2004 Dec; 35(4):1028-33. PubMed ID: 15916110
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
    Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
    Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of dietary oxalate and calcium on urinary oxalate and risk of formation of calcium oxalate kidney stones.
    Massey LK; Roman-Smith H; Sutton RA
    J Am Diet Assoc; 1993 Aug; 93(8):901-6. PubMed ID: 8335871
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Diet and nutrition in nephrolitiasis].
    Miggiano GA; Migneco MG
    Clin Ter; 2007; 158(1):49-54. PubMed ID: 17405659
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Vitamin C and oxalate stones.
    Roth DA; Breitenfield RV
    JAMA; 1977 Feb; 237(8):768. PubMed ID: 576314
    [No Abstract]   [Full Text] [Related]  

  • 46. Ascorbic acid supplements and kidney stone risk.
    Hoffer LJ
    JAMA Intern Med; 2013 Jul; 173(14):1384. PubMed ID: 23877084
    [No Abstract]   [Full Text] [Related]  

  • 47. Renal oxalate excretion in calcium urolithiasis.
    Galosy R; Clarke L; Ward DL; Pak CY
    J Urol; 1980 Mar; 123(3):320-3. PubMed ID: 7359627
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Effect of etidronate disodium (EHDP) on calcium oxalate renal stones induced by synthetic 1 alpha(OH) vitamin D3 and ethylene glycol in rats].
    Kawamura J; Nonomura M; Okada Y; Yoshida O; Takashima M; Itokawa Y
    Hinyokika Kiyo; 1985 May; 31(5):749-62. PubMed ID: 3931444
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of large intake of ascorbic acid on urinary and plasma oxalic acid levels.
    Tsao CS; Salimi SL
    Int J Vitam Nutr Res; 1984; 54(2-3):245-9. PubMed ID: 6500850
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ascorbic acid and urinary oxalate.
    Posner H
    Ann Intern Med; 1984 Oct; 101(4):571-2. PubMed ID: 6476652
    [No Abstract]   [Full Text] [Related]  

  • 51. [The effects of high-dose ascorbic acid administration on the factors of lithogenesis in the rat].
    Sakly R; Zarrouk K; Hedhili A; Achour A; Kallel Z; Mbazzaa A
    Ann Urol (Paris); 1991; 25(5):242-5. PubMed ID: 1663724
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ascorbic acid supplements and kidney stone risk--reply.
    Tiselius HG; Åkesson A; Thomas LD
    JAMA Intern Med; 2013 Jul; 173(14):1384. PubMed ID: 23877085
    [No Abstract]   [Full Text] [Related]  

  • 53. Correction of subclinical ascorbate deficiency in patients receiving dialysis: effects on plasma oxalate, serum cholesterol, and capillary fragility.
    Tomson CR; Channon SM; Parkinson IS; McArdle P; Qureshi M; Ward MK; Laker MF
    Clin Chim Acta; 1989 Apr; 180(3):255-64. PubMed ID: 2743578
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of vitamin C supplements on urinary oxalate and pH in calcium stone-forming patients.
    Baxmann AC; De O G Mendonça C; Heilberg IP
    Kidney Int; 2003 Mar; 63(3):1066-71. PubMed ID: 12631089
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of calcium restriction on renal excretion of oxalate and the probability of stones in the various pathophysiological groups with calcium stones.
    Bataille P; Charransol G; Gregoire I; Daigre JL; Coevoet B; Makdassi R; Pruna A; Locquet P; Sueur JP; Fournier A
    J Urol; 1983 Aug; 130(2):218-23. PubMed ID: 6876264
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Effect of high-dose vitamin C on the formation of experimental renal stones in the rat].
    Cai SL; Wei KX; Yang SS
    Zhonghua Wai Ke Za Zhi; 1985 Mar; 23(3):174-7, 192. PubMed ID: 3158497
    [No Abstract]   [Full Text] [Related]  

  • 57. Hyperoxaluria and renal insufficiency due to ascorbic acid administration during total parenteral nutrition.
    Swartz RD; Wesley JR; Somermeyer MG; Lau K
    Ann Intern Med; 1984 Apr; 100(4):530-1. PubMed ID: 6422817
    [No Abstract]   [Full Text] [Related]  

  • 58. Battling quackery: attitudes about micronutrient supplements in American academic medicine.
    Goodwin JS; Tangum MR
    Arch Intern Med; 1998 Nov; 158(20):2187-91. PubMed ID: 9818798
    [No Abstract]   [Full Text] [Related]  

  • 59. Five treatment procedures evaluated for the elimination of ascorbate interference in the enzymatic determination of urinary oxalate.
    Inamdar KV; Raghavan KG; Pradhan DS
    Clin Chem; 1991 Jun; 37(6):864-8. PubMed ID: 2049851
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reduction of urinary oxalate by combined calcium and citrate administration without increase in urinary calcium oxalate stone formers.
    Ito H; Suzuki F; Yamaguchi K; Nishikawa Y; Kotake T
    Clin Nephrol; 1992 Jan; 37(1):14-8. PubMed ID: 1541059
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.